tiprankstipranks
Xilio Therapeutics (XLO)
NASDAQ:XLO
US Market
Want to see XLO full AI Analyst Report?

Xilio Therapeutics (XLO) Ownership - Who Owns Xilio Therapeutics?

218 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 30, 2026
xxxxxxxxxxxxx
$43950

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
325,422Insider4.95%2,928,798
178,046Institution2.71%1,602,414
110,605Institution1.68%995,445
33,250Insider0.51%299,250
24,766Insider0.38%222,894
13,055Institution0.20%117,495
10,000Insider0.15%90,000
8,219Institution0.12%73,971
6,371Insider0.10%57,339
1,370Institution0.02%12,330

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
110,605Institution1.68%995,445
13,055Institution0.20%117,495
1,107Institution0.02%9,963

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
142,440Institution2.16%1,297,628
35,606Institution0.54%324,371
8,165Institution0.12%73,648
1,116Institution0.02%10,066
254Institution<0.01%2,286

FAQ

Who Owns Xilio Therapeutics (XLO)?
Currently, no data Available
What percentage of Xilio Therapeutics (XLO) stock is held by institutional investors?
Currently, no data Available
What percentage of Xilio Therapeutics (XLO) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Xilio Therapeutics (XLO)?
Russo Rene owns the most shares of Xilio Therapeutics (XLO).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.